In re Application of VESTOLIT GMBH and CELANESE EUROPE B.V., Applicants, To Obtain Discovery for Use in a Foreign Proceeding Pursuant to 28 U.S.C. § 1782
Misc. No. 24-cv-1401-CFC
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
November 24, 2025
COLM F. CONNOLLY, CHIEF JUDGE
Wilmington, Delaware
Counsel for Petitioners
David A. Dorey, Gregory P. Ranzini, BLANK ROME LLP, Wilmington, Delaware; Kelsey M. Machado, BAKER & McKENZIE LLP, Houston, Texas; Carson J. Henderson, BAKER & McKENZIE LLP, Dallas, Texas
Counsel for Respondent
MEMORANDUM OPINION
COLM F. CONNOLLY
CHIEF JUDGE
Shell Chemical LP (Shell Chemical) has filed a Motion to Vacate Order Regarding Application to Obtain Discovery for Use in a Foreign Proceeding and to Dismiss this Action, to Quash the Subpoenas, or, Alternatively, for a Stay of the Proceedings. D.I. 27. I will grant the motion.
I. BACKGROUND
In July 2020, the European Commission ruled that four ethylene purchasers, including Vestolit GmbH (Vestolit) and Celanese Europe B.V. (Celanese), formed a cartel in violation of antitrust law between 2011 and 2017. D.I. 7-1. The Commission found that the purchasers coordinated their price negotiation strategy to influence the ethylene Monthly Contract Price (MCP), an intermediate benchmark for ethylene prices, with the goal of lowering the ethylene sales price below the competitive level in Belgium, France, Germany, and the Netherlands. D.I. 7 ¶¶ 5, 16; D.I. 29 ¶¶ 9-11. The Commission imposed fines but did not make any findings about the collusion having actual effects on the market or lowering the price of ethylene. D.I. 7-1 ¶ 71; D.I. 7 ¶ 16; D.I. 29 ¶ 10.
In March 2023, Shell Chemicals Europe, B.V. (SCE), an ethylene seller, sued the cartelists in a follow-on private damages litigation in the Amsterdam District Court (the Dutch Court). D.I. 7 ¶¶ 5, 17-19; D.I. 29 ¶ 22. SCE alleges in
After disagreement between the parties about access to documents and confidentiality, the Dutch Court in February 2024 ordered the parties to maintain a “Confidentiality Ring” accessible only to the Defendants’ lawyers and external counsel and required SCE to disclose data underlying its damages calculation and AlixPartners’ report. D.I. 29-3; D.I. 29-4; D.I. 7 ¶ 22; D.I. 29 ¶¶ 23, 24; D.I. 37-1 ¶¶ 8, 9. The Court also ruled that if Defendants required additional documents to validate SCE‘s damages reports, they could enter further discussions with SCE and, if those discussions were unproductive, file briefs requesting discovery with the court by July 2024. D.I. 37-1 ¶ 10; D.I. 29 ¶¶ 25, 28. After SCE provided them various documents, the cartelists filed briefs in July and November confirming that they had all the data they needed related to the damages calculation. D.I. 29-6; D.I. 29-8; see D.I. 29 ¶¶ 32-34; D.I. 37 ¶¶ 12-13.
On October 16, 2024, while the discovery motion was pending, Defendants served SCE with two letters requesting more information from SCE: (1) a list of Shell Entities represented by SCE and copies of mandates authorizing SCE to act on the Shell entities behalf, and (2) ethylene sales margin data of SCE and SCE‘s represented entities from 2010-2020 in Europe, North America, and Asia. D.I. 7-5; D.I. 7-6; D.I. 7 ¶¶ 30-32; D.I. 29 ¶ 39. SCE‘s original writ of summons stated that “[al]l Shell entities (potentially) affected by the Ethylene cartel have assigned
On December 20, 2024, Vestolit and Celanese (collectively, Applicants) filed in this Court an ex parte Application pursuant to
On March 12, 2025, Applicants served the two subpoenas on Shell Chemical. D.I. 23; D.I. 24. On April 23, Shell Chemical filed the pending motion. D.I. 27. On May 7, before Applicants filed their answering brief in opposition to the motion, the Dutch Court denied Vestolit‘s 843a Disclosure Motion. D.I. 36-1. The court found that for the time being, Vestolit has not shown a legitimate interest in ethylene margins for its defense or support for its supply-side collusion counterclaim and dismissed the request for remaining documents as a “fishing expedition.” D.I. 36-1 at 6-8. Following the ruling, Shell Chemical asked Applicants to withdraw the subpoenas, but Applicants declined and filed their Answering Brief. D.I. 42-1; D.I. 37. Shell Chemical then filed its Reply Brief and requested reasonable expenses for litigating the motion. D.I. 40.
II. LEGAL STANDARD
A district court has the authority to grant an application under
Recipients of a subpoena served pursuant to
III. DISCUSSION
Shell Chemical argues that I should vacate the order granting
A. Section 1782‘s Statutory Requirements
Shell Chemical argues that
“[D]iscovery sought pursuant to
Vestolit and Celanese have submitted credible sworn declarations to support their assertion that the documents requested via
Accordingly, Amgen has satisfied the “for use” requirement of
B. Application of the Intel Factors
Next, Shell Chemical argues that all four Intel factors weigh in favor of prohibiting discovery. D.I. 28 at 11.
1. Intel factor #1
The first factor favors Shell Chemical. This factor asks whether the discovery sought is “unobtainable” in the foreign forum because it is outside the foreign tribunal‘s jurisdictional reach. Intel, 542 U.S. at 264.
The parties agree that Shell Chemical is not a party in the Dutch Court proceeding. D.I. 28 at 11; D.I. 37 at 11. Applicants argue that the appropriate inquiry on the first factor is “whether the entity from which the discovery is sought is within the [foreign] court‘s reach.” D.I. 37 at 12 (citation omitted). But Applicants mischaracterize the first factor, which the Court articulated as follows in Intel:
[W]hen the person from whom discovery is sought is a participant in the foreign proceeding . . . the need for
§ 1782(a) aid generally is not as apparent as it ordinarily is when evidence is sought from a nonparticipant in the matter arising abroad. A foreign tribunal has jurisdiction over those appearing before it, and can itself order them to produce evidence. In contrast, nonparticipants in the foreign proceeding may be outside the foreign tribunal‘s jurisdictional reach; hence, their evidence, available in the United States, may be unobtainable absent§ 1782(a) aid.
Intel, 542 U.S. at 264 (citations omitted) (emphasis added). The first factor concerns not simply whether the party from whom discovery is sought is a participant in the foreign proceeding, but whether the discovery is obtainable in the foreign proceeding absent
2. Intel factor #2
The second Intel factor instructs me to consider the “nature of the foreign tribunal, the character of the proceedings underway abroad, and the receptivity of the foreign government or the court or agency abroad to U.S. federal-court judicial assistance.” Intel, 542 U.S. at 264. This factor slightly favors Shell Chemical.
Applicants argue that “the Dutch Court‘s May 7, 2025 Discovery Ruling does not implicate the
The Dutch Court may be receptive in the future to some of the evidence within the
3. Intel factor #3
The third factor favors Shell Chemical. When evaluating foreign receptivity, the district court may “consider whether the
“Adverse discovery rulings by foreign courts are not necessarily fatal for
Accordingly, this factor weighs in favor of Shell Chemical. See In re Nokia Techs. Oy, 2024 WL 1675025, at *4 (D. Del. Apr. 18, 2024) (“a perception that an applicant has side-stepped less-than-favorable discovery rules by resorting immediately to
4. Intel factor #4
The fourth factor favors Shell Chemical. “A district court evaluating a
Applicants describe their requests as “proportional to SCE‘s claims.” D.I. 37 at 20. Shell Chemical describes the subpoenas as “burdensome” and “wildly overbroad.” D.I. 40 at 8-9. Both parties provide expert declarations supporting their characterizations of the discovery. E.g., D.I. 37-1 ¶¶ 19-20, 31
* * * *
In short, all four factors weigh in favor of vacating the subpoenas. Moreover, neither of the aims of
C. Fees
Finally, I will deny Shell Chemical‘s request for “an award of its reasonable expenses under
IV. CONCLUSION
Although Applicants have met the statutory requirements for a
The Court will issue an Order consistent with this Memorandum Opinion.
